Sergio Martines
Vorstandsvorsitzender bei Canapar Srl
Profil
Sergio Martines is currently the Chief Executive Officer at Canapar Srl and the Chief Executive Officer & Director at Sintalica Corp.
He was previously the President & Chief Executive Officer at NSP Pharma Corp., the Chief Executive Officer & Director at Canapar Corp., and a Director & Vice President at RAMM Pharma Corp.
in 2021.
Aktive Positionen von Sergio Martines
| Unternehmen | Position | Beginn |
|---|---|---|
Canapar Srl
 Canapar Srl Agricultural Commodities/MillingProcess Industries Part of RAMM Pharma Corp., Canapar Srl is an Italian company that engages in cannabis farming. The company is based in Ragusa, Italy. The company was founded in 2018. The CEO is Sergio Martines. | Vorstandsvorsitzender | - |
Sintalica Corp.
 Sintalica Corp. BiotechnologyHealth Technology Part of Huxley Health, Inc. (Canada), Sintalica Corp. is a Canadian drug discovery company. The company is based in Toronto, Canada. Sintalica was acquired by Huxley Health, Inc. (Canada) on September 26, 2023 for $5.34 million. The CEO of the company is Sergio Martines. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Sergio Martines
| Unternehmen | Position | Ende |
|---|---|---|
| RAMM PHARMA CORP. | Direktor/Vorstandsmitglied | 15.09.2021 |
Canapar Corp.
 Canapar Corp. Pharmaceuticals: OtherHealth Technology Canapar Corp. engages in organic farming of cannabis and the process of its derivatives. The company was founded on April 25, 2018 and is headquartered in Toronto, Canada. | Vorstandsvorsitzender | 14.06.2021 |
NSP Pharma Corp.
 NSP Pharma Corp. Drugstore ChainsRetail Trade NSP Pharma Corp. markets and distributes cosmeceutical anti-aging solutions and nutraceutical products. It sells its products directly to the public through its e-commerce website. The firm is a cosmeceutical and pharmaceutical company that markets antiaging products retail drug and department store chains in the United States and Canada. The company was founded on July 3, 2003 and is headquartered in Torotno, ON. | Präsident | 27.07.2006 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RAMM PHARMA CORP. | Consumer Non-Durables |
| Private Unternehmen | 4 |
|---|---|
NSP Pharma Corp.
NSP Pharma Corp. Drugstore ChainsRetail Trade NSP Pharma Corp. markets and distributes cosmeceutical anti-aging solutions and nutraceutical products. It sells its products directly to the public through its e-commerce website. The firm is a cosmeceutical and pharmaceutical company that markets antiaging products retail drug and department store chains in the United States and Canada. The company was founded on July 3, 2003 and is headquartered in Torotno, ON. | Retail Trade |
Canapar Corp.
Canapar Corp. Pharmaceuticals: OtherHealth Technology Canapar Corp. engages in organic farming of cannabis and the process of its derivatives. The company was founded on April 25, 2018 and is headquartered in Toronto, Canada. | Health Technology |
Canapar Srl
Canapar Srl Agricultural Commodities/MillingProcess Industries Part of RAMM Pharma Corp., Canapar Srl is an Italian company that engages in cannabis farming. The company is based in Ragusa, Italy. The company was founded in 2018. The CEO is Sergio Martines. | Process Industries |
Sintalica Corp.
Sintalica Corp. BiotechnologyHealth Technology Part of Huxley Health, Inc. (Canada), Sintalica Corp. is a Canadian drug discovery company. The company is based in Toronto, Canada. Sintalica was acquired by Huxley Health, Inc. (Canada) on September 26, 2023 for $5.34 million. The CEO of the company is Sergio Martines. | Health Technology |
